Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence

The prevalence of neuropsychiatric disorders following traumatic brain injury (TBI) is 20%–50%, and disorders of mood and cognition may remain even after recovery of neurologic function is achieved. Selective serotonin reuptake inhibitors (SSRI) block the reuptake of serotonin in presynaptic cells t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, John K., Burke, John F., Upadhyayula, Pavan S., Winkler, Ethan A., Deng, Hansen, Robinson, Caitlin K., Pirracchio, Romain, Suen, Catherine G., Sharma, Sourabh, Ferguson, Adam R., Ngwenya, Laura B., Stein, Murray B., Manley, Geoffrey T., Tarapore, Phiroz E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575613/
https://www.ncbi.nlm.nih.gov/pubmed/28757598
http://dx.doi.org/10.3390/brainsci7080093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575613/
https://www.ncbi.nlm.nih.gov/pubmed/28757598
http://dx.doi.org/10.3390/brainsci7080093

Ejemplares similares